S. Adachi

发表

Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential Hypertension.

S. Miura, K. Saku, K. Motozato, 2017, International heart journal.

Efficacy and safety of two single-pill fixed-dose combinations of angiotensin II receptor blockers/calcium channel blockers in hypertensive patients (EXAMINER study)

S. Miura, K. Saku, K. Motozato, 2016, Clinical and experimental hypertension.

Depressor and Anti-Inflammatory Effects of Angiotensin II Receptor Blockers in Metabolic and/or Hypertensive Patients With Coronary Artery Disease: A Randomized, Prospective Study (DIAMOND Study)

S. Miura, K. Saku, M. Sugihara, 2016, Journal of clinical medicine research.

Association between smoking habits and severity of coronary stenosis as assessed by coronary computed tomography angiography

S. Miura, K. Saku, A. Nakamura, 2016, Heart and Vessels.

Impact of the Absolute Difference in Diastolic Blood Pressure Between Arms in Patients With Coronary Artery Disease

S. Miura, K. Saku, M. Sugihara, 2015, Journal of clinical medicine research.

Associations between parameters of flow-mediated vasodilatation obtained by continuous measurement approaches and the presence of coronary artery disease and the severity of coronary atherosclerosis

S. Miura, K. Saku, Yasunori Suematsu, 2016, Clinical and experimental hypertension.

Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients

S. Miura, K. Saku, M. Ogawa, 2015, Journal of clinical medicine research.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Mehrad Amin Eskandari, J. F. Tinto, A. Capucci, 2018, Indian heart journal.

Ratio of eicosapentaenoic acid to arachidonic acid is a critical risk factor for acute coronary syndrome in middle-aged older patients as well as younger adult patients.

R. Matsukawa, S. Miura, K. Saku, 2014, Journal of cardiology.

Association between the severity of coronary artery stenosis and the combination of the difference in blood pressure between arms and brachial-ankle pulse wave velocity

S. Miura, K. Saku, A. Nakamura, 2016, Clinical and experimental hypertension.

Effects of Tolvaptan With or Without the Pre-Administration of Renin-Angiotensin System Blockers in Hospitalized Patients With Acute Decompensated Heart Failure.

S. Miura, K. Saku, T. Kuwano, 2017, International heart journal.

Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease

S. Miura, S. Imaizumi, Y. Uehara, 2016, Heart and Vessels.

Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study

S. Jimi, H. Urata, Yoshihiko Nakamura, 2020, Journal of Pharmaceutical Health Care and Sciences.

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

Michael A. Rodriguez, M. S. Lee, S. W. Park, 2019, Journal of the American Heart Association.

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data

Pedro F. Campos, Roger A. Nadeau, Jonathan B Sumner, 2021, BMJ.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.